FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947470908> ?p ?o ?g. }

• W2947470908 endingPage "1974" @default.
• W2947470908 startingPage "1964" @default.
• W2947470908 abstract "Background: Tendon-bone interface (TBI) injuries are common in sports activities. Owing to the limited regenerative ability of the TBI, its functional healing remains a difficulty in clinical practice. Icariin (ICA) provides strong stimulation for osteogenesis. Platelet-rich plasma (PRP) can be used as a carrier for bioactive molecules, although its ability to provide sustained release for such molecules needs improvement. Hypothesis: Freeze-dried PRP (FD-PRP) as a carrier for ICA can provide sustained release of ICA into the tendon-bone (T-B) healing site, thus accelerating T-B healing. Study Design: Controlled laboratory study. Methods: A total of 84 New Zealand rabbits with partial patellectomy in the hindlimb were randomly allocated into 3 different treatments: ICA incorporated with FD-PRP (ICA/FD-PRP), FD-PRP alone (FD-PRP), or saline control (CTL). The rabbit patella–patellar tendon (PP) interfaces were postoperatively harvested at postoperative week 8 or 16 for gross, radiological, histological, and mechanical evaluations. Results: Our results showed that FD-PRP can act as a carrier for sustained release of ICA into the T-B healing site. Macroscopically, no signs of infection or osteoarthritis were shown in the regenerated PP interfaces, and the area of cartilaginous metaplasia in the FD-PRP and ICA/FD-PRP groups at postoperative week 16 was significantly larger than that of the CTL group ( P < .05 for all). Radiologically, micro–computed tomography showed that new bone which formed at the healing site in the ICA/FD-PRP group was significantly increased, remodeled, and mineralized in comparison with the CTL group ( P < .05 for all). Histologically, the ICA/FD-PRP group exhibited a significant native PP interface, as shown by the enlargement and remodeling of new bone, well-organized collagen fibers, and robust production of proteoglycans in the regenerated fibrocartilage. The mechanical strength of the regenerated PP interface was significantly improved in the ICA/FD-PRP group. Significantly higher failure load and stiffness were shown in the ICA/FD-PRP group compared with the CTL and FD-PRP groups, respectively ( P < .05 for all). Conclusion: FD-PRP is a suitable sustained-release carrier for ICA, and ICA/FD-PRP can provide sustained release of ICA into the T-B healing site, thus effectively accelerating T-B healing. Clinical Relevance: Findings of this study demonstrate the feasibility of using FD-PRP as a carrier for ICA to improve T-B healing and provide a foundation for future clinical application." @default.
• W2947470908 created "2019-06-07" @default.
• W2947470908 creator A5017546410 @default.
• W2947470908 creator A5032809481 @default.
• W2947470908 creator A5049531982 @default.
• W2947470908 creator A5055913143 @default.
• W2947470908 creator A5056224435 @default.
• W2947470908 creator A5058285011 @default.
• W2947470908 creator A5067304676 @default.
• W2947470908 creator A5072187328 @default.
• W2947470908 creator A5079711130 @default.
• W2947470908 date "2019-05-31" @default.
• W2947470908 modified "2023-09-26" @default.
• W2947470908 title "Autologous Freeze-Dried, Platelet-Rich Plasma Carrying Icariin Enhances Bone-Tendon Healing in a Rabbit Model" @default.
• W2947470908 cites W1563806251 @default.
• W2947470908 cites W1968305182 @default.
• W2947470908 cites W1971294982 @default.
• W2947470908 cites W1977611517 @default.
• W2947470908 cites W1980597015 @default.
• W2947470908 cites W1998305047 @default.
• W2947470908 cites W2002685309 @default.
• W2947470908 cites W2003996063 @default.
• W2947470908 cites W2017351460 @default.
• W2947470908 cites W2028261415 @default.
• W2947470908 cites W2040679926 @default.
• W2947470908 cites W2052413186 @default.
• W2947470908 cites W2056427474 @default.
• W2947470908 cites W2062148402 @default.
• W2947470908 cites W2084041307 @default.
• W2947470908 cites W2087272622 @default.
• W2947470908 cites W2088249192 @default.
• W2947470908 cites W2095056299 @default.
• W2947470908 cites W2134739759 @default.
• W2947470908 cites W2139072455 @default.
• W2947470908 cites W2140340134 @default.
• W2947470908 cites W2156622891 @default.
• W2947470908 cites W2164816019 @default.
• W2947470908 cites W2169021301 @default.
• W2947470908 cites W2169904183 @default.
• W2947470908 cites W2270715540 @default.
• W2947470908 cites W2316280644 @default.
• W2947470908 cites W2467310656 @default.
• W2947470908 cites W2509263457 @default.
• W2947470908 cites W2534415341 @default.
• W2947470908 cites W2536899804 @default.
• W2947470908 cites W2537759612 @default.
• W2947470908 cites W2554217991 @default.
• W2947470908 cites W2582650077 @default.
• W2947470908 cites W2596948781 @default.
• W2947470908 cites W2608036794 @default.
• W2947470908 cites W2610969045 @default.
• W2947470908 cites W2766075424 @default.
• W2947470908 cites W2766666314 @default.
• W2947470908 cites W2802576156 @default.
• W2947470908 cites W2804797679 @default.
• W2947470908 cites W2883163865 @default.
• W2947470908 cites W2886676652 @default.
• W2947470908 cites W2890644178 @default.
• W2947470908 cites W2911792656 @default.
• W2947470908 doi "https://doi.org/10.1177/0363546519849657" @default.
• W2947470908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31150275" @default.
• W2947470908 hasPublicationYear "2019" @default.
• W2947470908 type Work @default.
• W2947470908 sameAs 2947470908 @default.
• W2947470908 citedByCount "15" @default.
• W2947470908 countsByYear W29474709082020 @default.
• W2947470908 countsByYear W29474709082021 @default.
• W2947470908 countsByYear W29474709082022 @default.
• W2947470908 countsByYear W29474709082023 @default.
• W2947470908 crossrefType "journal-article" @default.
• W2947470908 hasAuthorship W2947470908A5017546410 @default.
• W2947470908 hasAuthorship W2947470908A5032809481 @default.
• W2947470908 hasAuthorship W2947470908A5049531982 @default.
• W2947470908 hasAuthorship W2947470908A5055913143 @default.
• W2947470908 hasAuthorship W2947470908A5056224435 @default.
• W2947470908 hasAuthorship W2947470908A5058285011 @default.
• W2947470908 hasAuthorship W2947470908A5067304676 @default.
• W2947470908 hasAuthorship W2947470908A5072187328 @default.
• W2947470908 hasAuthorship W2947470908A5079711130 @default.
• W2947470908 hasConcept C126322002 @default.
• W2947470908 hasConcept C126894567 @default.
• W2947470908 hasConcept C141071460 @default.
• W2947470908 hasConcept C142724271 @default.
• W2947470908 hasConcept C204787440 @default.
• W2947470908 hasConcept C2776164576 @default.
• W2947470908 hasConcept C2777397205 @default.
• W2947470908 hasConcept C2780076745 @default.
• W2947470908 hasConcept C2780105995 @default.
• W2947470908 hasConcept C2780685212 @default.
• W2947470908 hasConcept C42219234 @default.
• W2947470908 hasConcept C71924100 @default.
• W2947470908 hasConcept C8337478 @default.
• W2947470908 hasConcept C89560881 @default.
• W2947470908 hasConceptScore W2947470908C126322002 @default.
• W2947470908 hasConceptScore W2947470908C126894567 @default.
• W2947470908 hasConceptScore W2947470908C141071460 @default.
• W2947470908 hasConceptScore W2947470908C142724271 @default.
• W2947470908 hasConceptScore W2947470908C204787440 @default.

• next